Ubisoft Stock: Barclays Raises Target, Shares Break Through €5.34 Resistance
The stock of the French video game publisher continues its technical rebound in mid-morning trading, after last week's post-annual results shock. The stock breaks a closely watched technical threshold and is among the top gainers in the SBF 120. Barclays raises its target at the same time.
Ubisoft Breaks Through €5.34 Resistance and Advances 2.84% in Session
Ubisoft's stock is up 2.84% at €5.43 in mid-morning trading, among the strongest gains in the SBF 120, while the index is down 1.01% and the CAC 40 loses 1.04%. The stock has broken above its €5.34 resistance during the session and is maintaining above it, extending the rebound that began after an 18% drop following the annual accounts published on May 20. On the moving averages front, the price is now 8.1% above the MM20 (€5.02) and 19% above the MM50 (€4.56), but remains 14.5% below the MM200 (€6.35), reflecting the still significant annual decline (-43.48% over one year). The RSI at 58 indicates a buying momentum without excess. Over three months, the stock has gained 27.91%. According to statements reviewed, ten funds still accumulate 15.03% of the capital sold short, up 0.52 points over thirty days. A high level that signals a significant portion of the float remains positioned against the stock, to be followed without drawing isolated conclusions.
Barclays Raises Target to €5.45, Anticipating a Denser Pipeline
Barclays recently raised its price target on Ubisoft from €4.30 to €5.45, while maintaining its market-weight opinion. The new target is nearly at the current price level, reflecting alignment with the recent rebound rather than a signal of marked potential. At the announcement of the annual results for 2025/2026 (on May 20, 2026), the group reported a 21.8% decline in revenue and a negative net IFRS result, but highlighted a reduction in net debt from €885 million to €187.3 million. The management discussed a 'significantly stronger and more diversified' content pipeline for fiscal years 2027-28 and 2028-29, a key argument supporting the thesis of a possible recovery. The ability of the stock price to remain above the €5.34 threshold crossed will be the technical reference for the coming sessions.
